These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 1550118)
21. Use of X chromosome inactivation analysis to establish carrier status for X-linked severe combined immunodeficiency. Goodship J; Malcolm S; Lau YL; Pembrey ME; Levinsky RJ Lancet; 1988 Apr; 1(8588):729-32. PubMed ID: 2895261 [TBL] [Abstract][Full Text] [Related]
22. Canine X-linked severe combined immunodeficiency. Felsburg PJ; Hartnett BJ; Henthorn PS; Moore PF; Krakowka S; Ochs HD Vet Immunol Immunopathol; 1999 Aug; 69(2-4):127-35. PubMed ID: 10507300 [TBL] [Abstract][Full Text] [Related]
23. Analysis of X-chromosome inactivation in bone marrow precursors from carriers of Wiskott-Aldrich syndrome and X-linked severe combined immunodeficiency: evidence that the Wiskott-Aldrich gene is expressed prior to granulocyte-macrophage colony-forming-unit. Mantuano E; Candotti F; Giliani S; Parolini O; Lusardi M; Zucchi M; Lanfranchi A; Porta F; Airò P; Albertini A Immunodeficiency; 1993; 4(1-4):271-6. PubMed ID: 8167717 [No Abstract] [Full Text] [Related]
24. Comparison of five retrovirus vectors containing the human IL-2 receptor gamma chain gene for their ability to restore T and B lymphocytes in the X-linked severe combined immunodeficiency mouse model. Avilés Mendoza GJ; Seidel NE; Otsu M; Anderson SM; Simon-Stoos K; Herrera A; Hoogstraten-Miller S; Malech HL; Candotti F; Puck JM; Bodine DM Mol Ther; 2001 Apr; 3(4):565-73. PubMed ID: 11319919 [TBL] [Abstract][Full Text] [Related]
25. Analysis of X-chromosome inactivation in X-linked immunodeficiency with hyper-IgM (HIGM1): evidence for involvement of different hematopoietic cell lineages. Notarangelo LD; Parolini O; Albertini A; Duse M; Mazzolari E; Plebani A; Camerino G; Ugazio AG Hum Genet; 1991 Dec; 88(2):130-4. PubMed ID: 1757090 [TBL] [Abstract][Full Text] [Related]
26. X-linked severe combined immunodeficiency in a family of Cardigan Welsh corgis. Pullen RP; Somberg RL; Felsburg PJ; Henthorn PS J Am Anim Hosp Assoc; 1997; 33(6):494-9. PubMed ID: 9358416 [TBL] [Abstract][Full Text] [Related]
27. Evidence that mutations in the X-linked DDP gene cause incompletely penetrant and variable skewed X inactivation. Plenge RM; Tranebjaerg L; Jensen PK; Schwartz C; Willard HF Am J Hum Genet; 1999 Mar; 64(3):759-67. PubMed ID: 10053010 [TBL] [Abstract][Full Text] [Related]
28. X-linked thrombocytopenia and Wiskott-Aldrich syndrome: similar regional assignment but distinct X-inactivation pattern in carriers. De Saint-Basile G; Schlegel N; Caniglia M; Le Deist F; Kaplan C; Lecompte T; Piller F; Fischer A; Griscelli C Ann Hematol; 1991 Aug; 63(2):107-10. PubMed ID: 1912030 [TBL] [Abstract][Full Text] [Related]
29. Histologic characterization of the thymus in canine X-linked severe combined immunodeficiency. Snyder PW; Kazacos EA; Felsburg PJ Clin Immunol Immunopathol; 1993 Apr; 67(1):55-67. PubMed ID: 8443985 [TBL] [Abstract][Full Text] [Related]
30. The molecular basis of X-linked severe combined immunodeficiency: defective cytokine receptor signaling. Leonard WJ Annu Rev Med; 1996; 47():229-39. PubMed ID: 8712778 [TBL] [Abstract][Full Text] [Related]
31. Prenatal diagnosis and genetic analysis of X-linked immunodeficiency disorders. Puck JM Pediatr Res; 1993 Jan; 33(1 Suppl):S29-33; discussion S33-4. PubMed ID: 8433872 [TBL] [Abstract][Full Text] [Related]
32. Clinical features and skewed X-chromosome inactivation in female carriers of X-linked recessive spinal and bulbar muscular atrophy. Ishihara H; Kanda F; Nishio H; Sumino K; Chihara K J Neurol; 2001 Oct; 248(10):856-60. PubMed ID: 11697521 [TBL] [Abstract][Full Text] [Related]
33. Carrier detection in X-linked immunodeficiencies. I: A PCR-based X chromosome inactivation assay at the MAOA locus. Hendriks RW; Chen ZY; Hinds H; Schuurman RK; Craig IW Immunodeficiency; 1993; 4(1-4):209-11. PubMed ID: 8167702 [TBL] [Abstract][Full Text] [Related]
34. Genetic localisation of mental retardation with spastic diplegia to the pericentromeric region of the X chromosome: X inactivation in female carriers. Martínez F; Tomás M; Millán JM; Fernández A; Palau F; Prieto F J Med Genet; 1998 Apr; 35(4):284-7. PubMed ID: 9598720 [TBL] [Abstract][Full Text] [Related]
35. Carrier detection of the X-linked primary immunodeficiency diseases using X-chromosome inactivation analysis. Winkelstein JA; Fearon E J Allergy Clin Immunol; 1990 Jun; 85(6):1090-7. PubMed ID: 2191994 [TBL] [Abstract][Full Text] [Related]
36. Carrier detection in X-linked immunodeficiencies. II: An X inactivation assay based on differential methylation of a line-1 repeat at the DXS255 locus. Hinds H; Craig IW; Chen ZY; Kraakman ME; Schuurman RK; Hendriks RW Immunodeficiency; 1993; 4(1-4):213-5. PubMed ID: 8167703 [TBL] [Abstract][Full Text] [Related]
37. [X chromosome inactivation--a biological phenomenon of clinical significance for women]. Orstavik KH Tidsskr Nor Laegeforen; 1999 Mar; 119(7):972-5. PubMed ID: 10210959 [TBL] [Abstract][Full Text] [Related]
38. The molecular basis of X-linked severe combined immunodeficiency: the role of the interleukin-2 receptor gamma chain as a common gamma chain, gamma c. Leonard WJ; Noguchi M; Russell SM; McBride OW Immunol Rev; 1994 Apr; 138():61-86. PubMed ID: 8070818 [TBL] [Abstract][Full Text] [Related]
39. The interleukin-2 receptor gamma chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1. Puck JM; Deschênes SM; Porter JC; Dutra AS; Brown CJ; Willard HF; Henthorn PS Hum Mol Genet; 1993 Aug; 2(8):1099-104. PubMed ID: 8401490 [TBL] [Abstract][Full Text] [Related]